Elia Mario Biganzoli
Elia Mario Biganzoli
Professor of Medical Statistics, University of Milano
unimi.it üzerinde doğrulanmış e-posta adresine sahip
Alıntı yapanlar
Alıntı yapanlar
Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation
R Cappato, H Calkins, SA Chen, W Davies, Y Iesaka, J Kalman, YH Kim, ...
Circulation: Arrhythmia and Electrophysiology 3 (1), 32-38, 2010
Vascular integrin alpha (v) beta3: a new prognostic indicator in breast cancer.
G Gasparini, PC Brooks, E Biganzoli, PB Vermeulen, E Bonoldi, LY Dirix, ...
Clinical Cancer Research 4 (11), 2625-2634, 1998
Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach
E Biganzoli, P Boracchi, L Mariani, E Marubini
Statistics in medicine 17 (10), 1169-1186, 1998
Quality of life and length of survival in advanced cancer patients on home parenteral nutrition
F Bozzetti, L Cozzaglio, E Biganzoli, G Chiavenna, M De Cicco, D Donati, ...
Clinical nutrition 21 (4), 281-288, 2002
Response to Cyclophosphamide, Methotrexate, and Fluorouracil in Lymph Node–Positive Breast Cancer According to HER2 Overexpression and Other Tumor …
S Ménard, P Valagussa, S Pilotti, L Gianni, E Biganzoli, P Boracchi, ...
Journal of Clinical Oncology 19 (2), 329-335, 2001
Lecture notes in computer science (including subseries lecture notes in artificial intelligence and lecture notes in bioinformatics): Preface
M Abe, K Aoki, G Ateniese, R Avanzi, Z Beerliová, O Billet, A Biryukov, ...
Lecture Notes in Computer Science (including subseries Lecture Notes in …, 2006
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or …
G Gasparini, M Toi, R Miceli, PB Vermeulen, R Dittadi, E Biganzoli, ...
The cancer journal from Scientific American 5 (2), 101-111, 1999
Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review
S Ferraro, F Braga, M Lanzoni, P Boracchi, EM Biganzoli, M Panteghini
Journal of clinical pathology 66 (4), 273-281, 2013
Genomic characterization of primary invasive lobular breast cancer
C Desmedt, G Zoppoli, G Gundem, G Pruneri, D Larsimont, M Fornili, ...
Journal of clinical oncology 34 (16), 1872-1881, 2016
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer
A Moliterni, S Ménard, P Valagussa, E Biganzoli, P Boracchi, A Balsari, ...
Journal of clinical oncology 21 (3), 458-462, 2003
A time‐dependent discrimination index for survival data
L Antolini, P Boracchi, E Biganzoli
Statistics in medicine 24 (24), 3927-3944, 2005
Evaluation of ANN and SVM classifiers as predictors to the diagnosis of students with learning disabilities
TK Wu, SC Huang, YR Meng
Expert Systems with Applications 34 (3), 1846-1856, 2008
Recurrence dynamics for non–small-cell lung cancer: effect of surgery on the development of metastases
R Demicheli, M Fornili, F Ambrogi, K Higgins, JA Boyd, E Biganzoli, ...
Journal of Thoracic Oncology 7 (4), 723-730, 2012
A ‘non-parametric’version of the naive Bayes classifier
D Soria, JM Garibaldi, F Ambrogi, EM Biganzoli, IO Ellis
Knowledge-Based Systems 24 (6), 775-784, 2011
Improving outcome prediction of systemic sclerosis from isolated Raynaud’s phenomenon: role of autoantibodies and nail-fold capillaroscopy
F Ingegnoli, P Boracchi, R Gualtierotti, EM Biganzoli, S Zeni, C Lubatti, ...
Rheumatology 49 (4), 797-805, 2010
Challenges in projecting clustering results across gene expression–profiling datasets
L Lusa, LM McShane, JF Reid, L De Cecco, F Ambrogi, E Biganzoli, ...
JNCI: Journal of the National Cancer Institute 99 (22), 1715-1723, 2007
Randomized trial of fenretinide (4‐HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long‐term results
F Chiesa, N Tradati, R Grigolato, P Boracchi, E Biganzoli, N Crose, ...
International journal of cancer 115 (4), 625-629, 2005
Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients
P Querzoli, M Pedriali, R Rinaldi, AR Lombardi, E Biganzoli, P Boracchi, ...
Clinical cancer research 12 (22), 6696-6701, 2006
Prognostic role of serum CA15. 3 in 362 node-negative breast cancers. An old player for a new game
M Gion, P Boracchi, R Dittadi, E Biganzoli, L Peloso, R Mione, C Gatti, ...
European Journal of Cancer 38 (9), 1181-1188, 2002
Risk factors for postpartum hemorrhage in a cohort of 6011 Italian women
E Biguzzi, F Franchi, F Ambrogi, B Ibrahim, P Bucciarelli, B Acaia, ...
Thrombosis research 129 (4), e1-e7, 2012
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20